Observational studyBMJ open gastroenterology2026
Outcomes of risankizumab use in adults with Crohn's disease in a real-world setting (ARISE-CD): a multicentre, retrospective cohort study.
Thomas D Butler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.